Concepedia

Fengting Liu

FL

Statistics

Publications

49

Citations

2K

H-Index

29

Active since

2001

Affiliations

Queen Mary University of London(Current)

Shandong University

Tianjin Medical University Cancer Institute and Hospital

Second Hospital of Shandong University

Shanghai Institute of Organic Chemistry

Fengting Liu is an author at Queen Mary University of London specializing in molecular oncology, oncology, and life sciences.

ORCID

Publications per year

2001–2024

49

Publications

49

Apaf-1 protein deficiency confers resistance to cytochromec–dependent apoptosis in human leukemic cells

Li Jia, Srinivasa M. Srinivasula, Fengting Liu et al. · Blood · 2001 · 141 citations · Full text

, , +16

Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia

Li Jia, Andrew Clear, Fengting Liu et al. · Blood · 2014 · 108 citations · Full text

, , +9

Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20

Xuwen Guan, Huaqing Wang, Wei-Wei Ban et al. · Cell Death and Disease · 2020 · 102 citations · Full text

, , +16

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Fengting Liu, Samir Agrawal, Zanyar Movasaghi et al. · Blood · 2008 · 90 citations · Full text

, , +16

Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis

Ping Wang, Peiguo Wang, Becky Liu et al. · Oncotarget · 2015 · 85 citations · Full text

, , +17

1–5 of 49